PortfoliosLab logo

Arcutis Biotherapeutics, Inc. (ARQT)

Equity · Currency in USD · Last updated Nov 26, 2022

Company Info

ISINUS03969K1088
CUSIP03969K108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$17.73
Year Range$14.38 - $26.95
EMA (50)$19.03
EMA (200)$19.67
Average Volume$782.23K
Market Capitalization$1.12B

ARQTShare Price Chart


Loading data...

ARQTPerformance

The chart shows the growth of $10,000 invested in Arcutis Biotherapeutics, Inc. in Feb 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $8,243 for a total return of roughly -17.57%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
-13.94%
-2.57%
ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

ARQTCompare to other instruments

Search for stocks, ETFs, and funds to compare with ARQT

ARQTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M5.58%4.33%
6M-8.60%-0.78%
YTD-13.36%-15.53%
1Y1.35%-14.36%
5Y-6.62%8.18%
10Y-6.62%8.18%

ARQTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-27.15%17.80%8.20%4.83%3.42%2.06%13.84%11.09%-29.09%-7.48%1.64%
2021-2.99%25.21%-15.34%15.80%-21.34%3.57%-14.51%-9.26%12.85%-11.34%-21.77%25.17%
202021.90%12.14%-0.27%12.89%-9.87%-11.71%-6.10%16.87%-39.18%52.19%3.72%

ARQTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arcutis Biotherapeutics, Inc. Sharpe ratio is 0.02. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.200.40JuneJulyAugustSeptemberOctoberNovember
0.02
-0.60
ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

ARQTDividend History


Arcutis Biotherapeutics, Inc. doesn't pay dividends

ARQTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-51.41%
-16.06%
ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

ARQTWorst Drawdowns

The table below shows the maximum drawdowns of the Arcutis Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arcutis Biotherapeutics, Inc. is 61.11%, recorded on Jan 27, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.11%Feb 9, 2021245Jan 27, 2022
-51.71%Mar 24, 2020155Oct 30, 202067Feb 8, 2021222
-39.4%Mar 11, 20206Mar 18, 20202Mar 20, 20208
-6.89%Feb 27, 20202Feb 28, 20207Mar 10, 20209
-4.64%Feb 25, 20201Feb 25, 20201Feb 26, 20202
-3.77%Feb 11, 20205Feb 18, 20201Feb 19, 20206
-3.51%Feb 5, 20202Feb 6, 20201Feb 7, 20203

ARQTVolatility Chart

Current Arcutis Biotherapeutics, Inc. volatility is 36.46%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%JuneJulyAugustSeptemberOctoberNovember
36.46%
12.31%
ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)